TXG Earnings 10x Genomics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.10 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -0.35 | 2026-02-13 | 10-K |
| Q3 2025 | 2025-09-30 | -0.22 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.00 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.28 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -1.52 | 2026-02-13 | 10-K |
| Q3 2025 | 2024-09-30 | -1.11 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.82 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.50 | 2025-05-09 | 10-Q |
| FY 2025 | 2023-12-31 | -2.18 | 2026-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | -1.77 | 2024-10-29 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.97 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.44 | 2024-04-30 | 10-Q |
| FY 2024 | 2022-12-31 | -1.46 | 2025-02-13 | 10-K |
| Q3 2023 | 2022-09-30 | -1.31 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.94 | 2023-08-04 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.38 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -0.53 | 2024-02-15 | 10-K |
| Q3 2022 | 2021-09-30 | -0.36 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.21 | 2022-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.